Clinical & Pharma

West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results
Clinical & Pharma West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results

West Pharmaceutical Services has experienced significant financial success, with a notable 23.15% increase in its stock price, reaching $279.26. This surge is primarily driven by a higher-than-expected earnings report, surpassing Wall Street projections and signaling robust demand for its products.

Navigating PFAS Health Risks: Maine Doctor's Proactive Approach
Clinical & Pharma Navigating PFAS Health Risks: Maine Doctor's Proactive Approach

The widespread presence of perfluoroalkyl and polyfluoroalkyl substances, known as PFAS, has emerged as a modern environmental and health challenge. Recognized for their persistence in the environment, these "forever chemicals" have steadily infiltrated various aspects of daily life, becoming a

Will Africa's Pharma Market Hit $118 Billion by 2032?
Clinical & Pharma Will Africa's Pharma Market Hit $118 Billion by 2032?

Africa's pharmaceutical market is on the cusp of a transformative era, projected to expand from USD 64.2 billion in 2025 to USD 118.3 billion by 2032, at an impressive CAGR of 9.10%. The surge in this sector is largely attributed to an increase in chronic disease cases, improvements in regulatory

Weill Cancer Hub West Unites to Revolutionize Cancer Care
Clinical & Pharma Weill Cancer Hub West Unites to Revolutionize Cancer Care

In an unprecedented move aimed at transforming the landscape of cancer research and patient care, the Weill Cancer Hub West has been officially launched. This innovative, collaborative initiative has emerged as a response to the global cancer crisis, with an impressive $100 million matching grant

Can Art Drive Change in Public Health?
Clinical & Pharma Can Art Drive Change in Public Health?

In recent years, the field of public health has increasingly looked beyond traditional methods to engage with communities and convey complex messages. Art has emerged as a powerful tool that not only communicates health information effectively but also inspires behavioral changes. This intersection

Can UK Achieve Global Leadership in Life Sciences by 2035?
Clinical & Pharma Can UK Achieve Global Leadership in Life Sciences by 2035?

The UK Government's ambitious Life Sciences Sector Plan represents a transformative vision for the country, aspiring to establish it as a leading global player in biomedical innovation, economic growth, and national health resilience by 2035. At the heart of this strategic initiative lies the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later